The 3 analysts offering 1 year price forecasts for XBRANE have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to XBRANE in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
XBRANE EPS for the last quarter is −0.35 SEK despite the estimation of −0.38 SEK. In the next quarter EPS is expected to reach −0.05 SEK. Track more of XBRANE BIOPHARMA AB financials and stay on top of what is up with the company.
In the next quarter XBRANE BIOPHARMA AB revenue is expected to reach 57.75 M SEK. Check out XBRANE BIOPHARMA AB revenue and earnings and make informed decisions.
According to analysts, XBRANE price target is 1.17 SEK with a max estimate of 2.27 SEK and a min estimate of 0.60 SEK. Check if this forecast comes true in a year, meanwhile watch XBRANE BIOPHARMA AB stock price chart and keep track of the current situation with XBRANE news and stock market news.